Letters To The Editor
Copyright ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 21, 2017; 23(39): 7198-7200
Published online Oct 21, 2017. doi: 10.3748/wjg.v23.i39.7198
Duplicate publication bias weakens the validity of meta-analysis of immunosuppression after transplantation
Cameron J Fairfield, Ewen M Harrison, Stephen J Wigmore
Cameron J Fairfield, Ewen M Harrison, Stephen J Wigmore, Department of Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, United Kingdom
ORCID number: Cameron James Fairfield (0000-0001-7635-1868); Ewen M Harrison (0000-0002-5018-3066); Stephen J Wigmore (0000-0002-3614-8002).
Author contributions: Fairfield CJ wrote this letter; Harrison EM and Wigmore SJ revised the letter.
Conflict-of-interest statement: The authors have no conflict of interest to report.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Cameron J Fairfield, MBChB, Department of Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, 51 Little France Drive, Edinburgh EH16 4SA, United Kingdom. cameron.fairfield@nhs.net
Telephone: +44-131-2423614
Received: August 28, 2017
Peer-review started: August 29, 2017
First decision: September 13, 2017
Revised: September 15, 2017
Accepted: September 26, 2017
Article in press: September 26, 2017
Published online: October 21, 2017


Duplicate publication can introduce significant bias into a meta-analysis if studies are inadvertently included more than once. Many studies are published in more than one journal to maximize readership and impact of the study findings. Inclusion of multiple publications of the same study within a meta-analysis affords inappropriate weight to the duplicated data if reports of the same study are not linked together. As studies which have positive findings are more likely to be published in multiple journals this leads to a potential overestimate of the benefits of an intervention. Recent advances in immunosuppression strategies following liver transplantation have led to many studies investigating immunosuppressive regimes including immunosuppression monotherapy. In this letter we focus on a recently published meta-analysis by Lan et al investigating studies assessing immunosuppression monotherapy for liver transplantation. The authors claim to have identified fourteen separate randomised studies investigating immunosuppression monotherapy. Seven of the references appear to relate to only three studies which have been subject to duplicate publication. Several similarities can be identified in each of the duplicate publications including similar authorship, identical immunosuppression regimes, identical dates of enrolment and citation of the original publication in the subsequent manuscripts. We discuss the evidence of the duplicate publication inclusion in the meta-analysis.

Key Words: Liver transplantation, Immunosuppression, Meta-analysis, Duplicate publication, Bias

Core tip: The purpose of this letter to the editor is to comment on the potential inclusion of duplicate publications within the meta-analysis titled: “Efficacy of immunosuppression monotherapy after liver transplantation: A meta-analysis”.

Citation: Fairfield CJ, Harrison EM, Wigmore SJ. Duplicate publication bias weakens the validity of meta-analysis of immunosuppression after transplantation. World J Gastroenterol 2017; 23(39): 7198-7200

We read with interest the article titled “Efficacy of immunosuppression monotherapy after liver transplantation: A meta-analysis” by Lan et al[1]. The authors have performed a meta-analysis assessing the use of immunosuppression monotherapy after liver transplantation. The authors claim to have included fourteen randomised studies comparing monotherapy vs combination immunosuppression for liver transplanted patients and conclude that calcineurin inhibitor monotherapy is both effective and leads to fewer adverse events than combination therapy. The authors state that the review is the first meta-analysis to include multiple studies assessing the effect of immunosuppression with or without steroids on graft rejection after liver transplantation. Finally, the authors state that the strengths of their review include duplicate study elimination. For the following reasons, we do not agree with their results or their conclusions.

The authors claim to have included fourteen separate randomised studies. On closer inspection, the authors have included seven references relating to only three randomised studies and have not made adequate efforts to eliminate duplicate studies[2-8].

The first of these studies was performed in the United Kingdom and both publications share the same start date, protocol, several co-authors and the same recruitment centres[2,3]. The earlier publication appears to record preliminary results[2]. Manousou et al[3] appear to have included these preliminary results as a separate study. Furthermore, the main publication relating to this study clearly states that the findings are “similar to those in our preliminary report”. The citation in support of this statement is identical to that included as a separate study in the meta-analysis by Lan et al[1].

The second of these studies was performed in Germany and both publications share the same enrolment dates, protocol, several co-authors, recruitment centre and numbers of patients allocated to each intervention arm[4,5]. Furthermore, the publication recording long-term follow-up for patients in this study explicitly states that the authors have previously published their study and that in the publication in 2010 they “present the results of a re-evaluation of our study patients”[5].

The third of these studies was performed in Italy and all three publications share the same enrolment dates, several co-authors, recruitment centre and protocol[6-8]. Furthermore, both duplicate studies with later publication dates explicitly state that the earlier publications are interim reports relating to the same study[6,7].

The authors also claim to have published the first meta-analysis assessing steroid-free immunosuppression in liver transplanted patients. Three meta-analyses[9-11] were published prior to the date of submission by Lan et al[1]. Two further meta-analyses have been published since this date[12,13]. In each case where any of the three studies discussed have been included in another meta-analyses the authors have concluded that the studies have been subject to duplicate publication.

The problem with inclusion of duplicated data in meta-analyses is that it creates bias with inappropriate weight being afforded to the duplicate data. The failure in Lan 2014 to adequately avoid duplicate publication bias may mean that the results of this meta-analysis are invalid.


Manuscript source: Unsolicited manuscript

Specialty type: Gastroenterology and hepatology

Country of origin: United Kingdom

Peer-review report classification

Grade A (Excellent): A

Grade B (Very good): B, B

Grade C (Good): C

Grade D (Fair): 0

Grade E (Poor): 0

P- Reviewer: Akamatsu N, Bramhall S, Chiu KW, Rodriguez-Peralvarez ML S- Editor: Gong ZM L- Editor: A E- Editor: Huang Y

1.  Lan X, Liu MG, Chen HX, Liu HM, Zeng W, Wei D, Chen P. Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis. World J Gastroenterol. 2014;20:12330-12340.  [PubMed]  [DOI]
2.  Samonakis DN, Mela M, Quaglia A, Triantos CK, Thalheimer U, Leandro G, Pesci A, Raimondo ML, Dhillon AP, Rolles K. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis. Transpl Infect Dis. 2006;8:3-12.  [PubMed]  [DOI]
3.  Manousou P, Samonakis D, Cholongitas E, Patch D, O’Beirne J, Dhillon AP, Rolles K, McCormick A, Hayes P, Burroughs AK. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy. Liver Transpl. 2009;15:1783-1791.  [PubMed]  [DOI]
4.  Moench C, Barreiros AP, Schuchmann M, Bittinger F, Thiesen J, Hommel G, Kraemer I, Otto G. Tacrolimus monotherapy without steroids after liver transplantation--a prospective randomized double-blinded placebo-controlled trial. Am J Transplant. 2007;7:1616-1623.  [PubMed]  [DOI]
5.  Weiler N, Thrun I, Hoppe-Lotichius M, Zimmermann T, Kraemer I, Otto G. Early steroid-free immunosuppression with FK506 after liver transplantation: long-term results of a prospectively randomized double-blinded trial. Transplantation. 2010;90:1562-1566.  [PubMed]  [DOI]
6.  Belli LS, de Carlis L, Rondinara G, Alberti AB, Bellati G, De Gasperi A, Forti D, Idèo G. Early cyclosporine monotherapy in liver transplantation: a 5-year follow-up of a prospective, randomized trial. Hepatology. 1998;27:1524-1529.  [PubMed]  [DOI]
7.  De Carlis L, Belli LS, Rondinara GF, Alberti A, Sansalone CV, Colella G, Aseni P, Slim AO, Forti D. Early steroid withdrawal in liver transplant patients: final report of a prospective randomized trial. Transplant Proc. 1997;29:539-542.  [PubMed]  [DOI]
8.  Romani F, Belli LS, De Carlis L, Rondinara GF, Alberti A, Sansalone CV, Bellati G, Zavaglia C, Fesce E, Ideo G. Cyclosporin monotherapy (after 3 months) in liver transplant patients: a prospective randomized trial. Transplant Proc. 1994;26:2683-2685.  [PubMed]  [DOI]
9.  Knight SR, Morris PJ. Steroid sparing protocols following nonrenal transplants; the evidence is not there. A systematic review and meta-analysis. Transpl Int. 2011;24:1198-1207.  [PubMed]  [DOI]
10.  Segev DL, Sozio SM, Shin EJ, Nazarian SM, Nathan H, Thuluvath PJ, Montgomery RA, Cameron AM, Maley WR. Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials. Liver Transpl. 2008;14:512-525.  [PubMed]  [DOI]
11.  Sgourakis G, Radtke A, Fouzas I, Mylona S, Goumas K, Gockel I, Lang H, Karaliotas C. Corticosteroid-free immunosuppression in liver transplantation: a meta-analysis and meta-regression of outcomes. Transpl Int. 2009;22:892-905.  [PubMed]  [DOI]
12.  Gu J, Wu X, Lu L, Zhang S, Bai J, Wang J, Li J, Ding Y. Role of steroid minimization in the tacrolimus-based immunosuppressive regimen for liver transplant recipients: a systematic review and meta-analysis of prospective randomized controlled trials. Hepatol Int. 2014;8:198-215.  [PubMed]  [DOI]
13.  Fairfield C, Penninga L, Powell J, Harrison EM, Wigmore SJ. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients. Cochrane Database Syst Rev. 2015;CD007606.  [PubMed]  [DOI]